Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_assertion type Assertion NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_head.
- NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_provenance.
- NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_assertion evidence source_evidence_literature NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_provenance.
- NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_assertion SIO_000772 19523815 NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_provenance.
- NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_assertion wasDerivedFrom gad-20150221 NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_provenance.
- NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_assertion wasGeneratedBy ECO_0000203 NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_provenance.